HEINER DREISMANN
Dr. Heiner Dreismann is the former President and CEO of Roche Molecular Systems (RMS), a division of F. Hoffmann-La Roche Ltd. and the company that pioneered molecular diagnostics in the clinical arena. Dr. Dreismann led the introduction of PCR-based tests in Europe as early as 1992 and witnessed first hand the industry growth over the last two decades. He held various management functions at Roche, including membership of the global Executive Committee of Roche Diagnostics. In 2000 he became President and CEO of Roche Molecular Systems (RMS) in Pleasanton, California. During his tenure as CEO, RMS annual sales doubled to US$ 1.0 billion and the portfolio of tests and hardware sales were greatly expanded. Prior to being appointed CEO, Dr. Dreismann held other senior positions within Roche Diagnostics in the areas of Global Business Development, Business Unit Manager for PCR and Microbiology, as well as R&D positions in microbiology and infectious diseases, and in manufacturing.
Dr. Dreismann earned a Master’s Degree in Biology and a PhD in Microbiology/Molecular Biology both from Westfaelische Wilhelms University in Muenster, Germany. Dr. Dreismann joined the Celula Board of Directors in 2009.
